Global C-Reactive Protein Testing Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
- SKU ID : GIR-GIR1807160123 12964768
- |
- Publishing Date: 15-Oct-2018
- |
- Region: Global
- |
- No. of pages: 137
C-Reactive Protein Tests are blood tests that measure the levels of C-Reactive Protein. C-reactive protein is a protein that is produced by the liver and its level increase when there is inflammation in the body.
Scope of the Report:
This report studies the C-Reactive Protein Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the C-Reactive Protein Testing market by product type and applications/end industries.
C-reactive tests identify and keep track of infections and diseases that cause inflammation such as certain types of cancers, cardiovascular diseases, arthritis, etc. C-reactive protein tests estimate the risks of a person suffering from heart attacks or strokes.
The global C-Reactive Protein Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of C-Reactive Protein Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Roche
EMD Millipore
Life technologies
Randox
Quest Diagnostics
Abaxis
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
ELISA
Immunoturbidimetric
Chemiluminesence immunoassay(CLIA)
High-sensitivity C-reactive protein (hsCRP) assay
Market Segment by Applications, can be divided into
Cardiovascular diseases
Infections
Diseases of immune system
Rhematoid arthritis
Cancers
Inflammatory bowel disease
Osteomyelitis
Scope of the Report:
This report studies the C-Reactive Protein Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the C-Reactive Protein Testing market by product type and applications/end industries.
C-reactive tests identify and keep track of infections and diseases that cause inflammation such as certain types of cancers, cardiovascular diseases, arthritis, etc. C-reactive protein tests estimate the risks of a person suffering from heart attacks or strokes.
The global C-Reactive Protein Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of C-Reactive Protein Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Roche
EMD Millipore
Life technologies
Randox
Quest Diagnostics
Abaxis
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
ELISA
Immunoturbidimetric
Chemiluminesence immunoassay(CLIA)
High-sensitivity C-reactive protein (hsCRP) assay
Market Segment by Applications, can be divided into
Cardiovascular diseases
Infections
Diseases of immune system
Rhematoid arthritis
Cancers
Inflammatory bowel disease
Osteomyelitis
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
